Resultados da pesquisa - "SFRH/BPD/80451/2011"

Catálogo de Publicações - "SFRH/BPD/80451/2011"

  • A mostrar 1 - 5 resultados de 5
Filtros
  1. 1

    Pharmacological potential of methylxanthines: Retrospective analysis and future expectations

    Publicação
    por Monteiro, João
    Outros Autores: Alves, Marco G; Oliveira, P.F.; Silva, Branca M.
    Origem: uBibliorum
    Methylated xanthines (methylxanthines) are available from a significant number of different botanical species. They are ordinarily included in daily diet, in many extremely common beverages and foods. Caffeine, theophylline and theobromine are the main methylxanthines available from natural sources. The supposedly relatively low toxicity of methylxanthines, combined with the many beneficial effects that have been attributed to these compounds through time, generated a justified attention and a very prolific ground for dedicated scientific reports. Methylxanthines have been widely used as therapeutical tools, in an intriguing range of medicinal scopes. In fact, methylxanthines have been/were medically used as Central Nervous System stimulants, bronchodilators, coronary dilators, diuretics and anti-cancer adjuvant treatments. Other than these applications, methylxanthines have also been hinted to hold other beneficial health effects, namely regarding neurodegenerative diseases, cardioprotection, diabetes and fertility. However, it seems now consensual that toxicity concerns related to methylxanthine consumption and/or therapeutic use should not be dismissed. Taking all the knowledge and expectations on the potential of methylxanthines into account, we propose a systematic look at the past and future of methylxanthine pharmacologic applications, discussing all the promise and anticipating possible constraints. Anyways, methylxanthines will still substantiate considerable meaningful research and discussion for years to come.
    2018 artigo Portugal acesso aberto
  2. 2

    Implications of epigallocatechin-3-gallate in cultured human Sertoli cells glycolytic and oxidative profile

    Publicação
    por Dias, Tânia R.
    Outros Autores: Alves, Marco G; Silva, Joaquina; Barros, Alberto; Sousa, Mário; Casal, Susana et al.
    Origem: uBibliorum
    Sertoli cells are crucial for the success of spermatogenesis, which is the biological process that ensures male fertility. These cells present high metabolic rates, being often subjected to high oxidative stress levels that, if uncontrolled, may compromise male fertility. Since the most abundant tea catechin, epigallocatechin-3-gallate (EGCG), has demonstrated a potent preventive activity against oxidative stress, we have evaluated its effect at concentrations of 5 and 50μM, on the metabolism, mitochondrial functionality and oxidative profile of human Sertoli cells (hSCs). While, the highest concentration of EGCG (50μM) increased glucose and pyruvate consumption, it decreased the conversion of pyruvate to alanine to sustain a regular lactate production. However, despite maintaining Krebs cycle functionality, EGCG (50μM) decreased mitochondrial membrane potential of hSCs, which could compromise the normal rates of ATP production. Interestingly, oxidative damages to proteins and lipids decreased in this experimental group, which may be valuable for the nutritional support of spermatogenesis.
    2017 artigo Portugal acesso aberto
  3. 3

    Regucalcin is an androgen-target gene in the rat prostate modulating cell-cycle and apoptotic pathways

    Publicação
    por Vaz, C V
    Outros Autores: Baptista, Cláudio; Marques, Ricardo; Gomes, Inês; Correia, Sara; Alves, Marco G et al.
    Origem: uBibliorum
    Regucalcin (RGN) is a calcium (Ca(2+) )-binding protein underexpressed in prostate adenocarcinoma comparatively to non-neoplastic prostate or benign prostate hyperplasia cases. Moreover, RGN expression is negatively associated with the cellular differentiation of prostate adenocarcinoma, suggesting that loss of RGN may be associated with tumor onset and progression. However, the RGN actions over the control of prostate cell growth have not been investigated.
    2014 artigo Portugal acesso restrito
  4. 4

    Phytochemical, nutritional, antioxidant and anticancer properties of Juglans regia (L.).

    Publicação
    por Silva, Branca M.
    Outros Autores: Nunes, Ana R.; Ramalhosa, Elsa; Pereira, J.A.; Alves, Marco G.; Oliveira, Pedro F.
    Juglans regia (L.) is a deciduous tree, spread throughout the world due to its nutritional and sensory value. Although walnuts, the J. regia seeds, have been part of the human diet for a long time, only in the recent years several studies have surfaced on this botanical species as a rich and inexpensive source of bioactive compounds. In fact, much research is available depicting the human health benefits of J. regia seeds, leaves and green husks for a wide variety of diseases mediated by oxidative stress, namelly cancer, and neurodegenerative disorders. Among bioactive compounds, polyphenols play an important role. They are well known for their strong antioxidant, antihemolytic, antidiabetic, antimicrobial, antimutagenic and anticarcinogenic activities and are considered by many researchers responsible for the beneficial health effects of J. regia and its derivatives. In this chapter, we aim to emphasize the phytochemical composition, nutritional value and health promoting properties of J. regia, especially those related to its antioxidant and anticancer activities. Among several nut types, walnut stands up as a functional food, rich in antioxidants, especially in phenolic compounds and tocopherols. The potential for J. regia to be used as both preventive and therapeutic measure in several human diseases is high. For that reason, a lot of attention has been given to J. regia in the last decade. Our chapter, summarizes the main studies about J. regia and its beneficial effects on human health, focusing on its antioxidant and anticancer activities.
    2016 capítulo de livro Portugal acesso restrito
  5. 5

    The progression from a lower to a higher invasive stage of bladder cancer is associated with severe alterations in glucose and pyruvate metabolism

    Publicação
    por Conde, Vanessa R.
    Outros Autores: Oliveira, Pedro F.; Nunes, Ana R.; Rocha, Cátia S.; Ramalhosa, Elsa; Pereira, J.A. et al.
    Cancer cells present a particular metabolic behavior. We hypothesized that the progression of bladder cancer could be accompanied by changes in cells glycolytic profile. We studied two human bladder cancer cells, RT4 and TCCSUP, in which the latter represents a more invasive stage. The levels of glucose, pyruvate, alanine and lactate in the extracellular media were measured by Proton Nuclear Magnetic Resonance. The protein expression levels of glucose transporters 1 (GLUT1) and 3 (GLUT3), monocarboxylate transporter 4 (MCT4), phosphofructokinase-1 (PFK1), glutamic-pyruvate transaminase (GPT) and lactate dehydrogenase (LDH) were determined. Our data showed that glucose consumption and GLUT3 levels were similar in both cell lines, but TCCSUP cells displayed lower levels of GLUT1 and PFK expression. An increase in pyruvate consumption, concordant with the higher levels of lactate and alanine production, was also detected in TCCSUP cells. Moreover, TCCSUP cells presented lower protein expression levels of GPT and LDH. These results illustrate that bladder cancer progression is associated with alterations in cells glycolytic profile, namely the switch from glucose to pyruvate consumption in the more aggressive stage. This may be useful to develop new therapies and to identify biomarkers for cancer progression.
    2015 artigo Portugal acesso restrito